You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market
- 2. Kexing Biopharm's New Cancer Drug Gets Peru Market Approval
- 3. Early prediction of colorectal adenoma risk: leveraging large-language model for clinical electronic medical record data
- 4. IGF2BP2 regulates gastric cancer radiotherapy resistance through HIF1α-mediated glycolysis
- 5. Cuproptosis as a therapeutic target in cancer: a Systematic Review and bibliometric analysis of the research landscape
- 6. Carrick Therapeutics Announces New Clinical Data Supporting Biomarker-driven Patient Selection for Samuraciclib (CDK7i) in Combination with SERDs in Hormone Receptor Positive Advanced Breast Cancer
- 7. NIH researchers discover tissue biomarker that may indicate higher risk of aggressive breast cancer development and death
- 8. Visualising the mechanics of hormone-driven gene activation: Insights into breast cancer
- 9. Synchronous papillary renal neoplasm with reverse polarity and membranous nephropathy: a rare case report
- 10. A simple approach to prevent skin damage from heat steam in robotic breast surgery
Last updated at 10:03 GMT
Hot News Makers
Health/Pharma Companies
-
28926.87
-
7243.22
-
4474.72
-
3601.76
-
2913.22
-
2351.37
-
1394.92
-
1385.71
-
483.87
-
371.93
Drugs, Treatments, Trials
-
1365.75
-
657.21
-
622.87
-
555.96
-
272.56
-
169.87
-
124.57
-
106.65
-
87.81
-
74.64
Last updated at 9:10 GMT
